Aging Is Associated with Increased Human T Cell CC Chemokine Receptor Gene Expression by Yung, Raymond L. & Mo, Ruran
JOURNAL OF INTERFERON & CYTOKINE RESEARCH 23:575–582 (2003)
© Mary Ann Liebert, Inc.
Aging Is Associated with Increased Human T Cell CC
Chemokine Receptor Gene Expression
RAYMOND L. YUNG and RURAN MO
ABSTRACT
Leukocyte chemokine receptors (CR) are central to the pathogenesis of many human diseases, including hu-
man immunodeficiency virus-1 (HIV-1) infection. Elderly individuals infected with the HIV-1 virus have a
shorter disease-free interval and worse clinic outcome. However, the reasons for this are unclear. We recently
reported increased CC chemokine receptor (CCR) expression in CD41 T cells in aged mice, but it is not known
if similar changes occur in humans. In addition, it is unclear if the observed differences are related to aged-
related expansion in the memory T cell compartment. In this report, we examined the effects of aging on CCR
gene expression in human peripheral blood mononuclear cells (PBMCs), CD41 T cells, and naive/memory T
cells. Aging is found to be associated with increased CCR1–5 expression in PBMCs and CD41 T cells. In ad-
dition, although the age-related increases in CCR expression occurred in both naive and memory T cells, the
greatest changes were seen in the memory T cell subset. We propose that the observed aging-associated in-
crease in T cell chemokine receptor expression may contribute to the worse clinical outcome of T cell chemokine
receptor-dependent disease, such as HIV-1 infection, in the elderly.
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INTRODUCTION
HUMAN AGING IS ASSOCIATED WITH THE DECLINE in the abil-ity to defend against a multitude of infections, including
the human immunodeficiency type 1 (HIV-1) virus. People $50
years constitute at least 10% of new acquired immunodeficiency
syndrome (AIDS) cases, representing the fastest growing HIV-
1-infected group.(1) Studies have shown that older patients have
a shorter observed AIDS-free interval and shorter survival,
along with more HIV and non-HIV-related comorbidity.(2–5)
Although the underlying cause for the discrepancy is unclear,
the increase in disease susceptibility and worse clinical outcome
in HIV-1 infection in the elderly are often attributed to poor
immunity in old age.
Chemokines, or chemotactic cytokines, and their counter-
receptors are increasingly recognized as critical components of
many normal and pathologic processes.(6,7) Depending on the
arrangement of the amino-terminal cysteine residues, these
7–11-kDa proteins are classified into four subfamilies: CC,
CXC, C, and CX3C. Bone marrow-derived cells are the main
targets of chemokines. Expression of the chemokine receptors
on leukocytes and the abundance of chemokines in the local
environment play critical roles in the guided migration of leuko-
cytes to areas of inflammation and immune response. The
leukocyte chemokine system received exponential attention
when it was discovered that specific chemokine receptors are
the required coreceptors for the productive entry of HIV-1 and
HIV-2 isolates into T cells and monocytes.(8,9) The level of
CD41 T cell chemokine receptor expression correlates closely
to HIV viral load(10) and disease progression.(11) However, de-
spite the established importance of the chemokine system in
normal and pathologic immune responses, very little is known
about this aspect of immunobiology in aging.
We recently examined the effect of aging on the expression
and function of murine CD41 T cell chemokine receptors.(12)
CD41 T cells from aged C57BL/6 and DBA/2 mice were shown
to overexpress the CC chemokine receptors CCR1, 2, 4, 5, 6,
and 8 and have lower expression of CCR7 and 9. The increased
chemokine receptor gene expression correlates with increased
protein expression and has important function consequences.
The difference in T cell chemokine receptor expression is reg-
ulated at the transcriptional or pretranscriptional level, as RNA
degradation studies showed equal or faster rate of chemokine
receptor RNA degradation in old vs. young T cells. Further-
more, caloric restriction partially or completely restored the ag-
ing changes. Expansion of the T memory cell compartment oc-
curs in both human and murine aging.(13) It is, therefore,
possible that the observed chemokine receptor changes in T
cells reflect the aging-associated shift in favor of memory CD41
T cells. In this report, we asked if T cell CC chemokine re-
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ceptor changes also occur in human aging and if these changes
occur in both the naive and memory CD41 T cell subsets. This
is an important question, as there are species-specific differ-
ences in chemokine receptor function. An important example
is that unlike their human counterparts, unmanipulated murine
T cells are resistant to HIV-1 infection.
MATERIALS AND METHODS
Human subjects
Community-dwelling adults aged $60 years were recruited
from the Human Subject Core of the Institution of Gerontology
and the outpatient geriatrics clinic at the University of Michi-
gan. All participants gave informed consent, and the protocol
was approved by the institutional review board of the Univer-
sity of Michigan. Young adults between the ages of 18 and 40
years were recruited by local advertising. Subjects ,18 years
were excluded from the study to avoid detecting developmen-
tal rather than aging-related changes. Exclusion criteria for both
young and old subjects included any history of recent (,2
weeks) or chronic infection, cancer, immune/autoimmune, or
any inflammatory condition requiring therapy with corticoste-
roids or immunomodulating agents, or significant anemia
(hematocrit ,38%).
T cell isolation
Peripheral blood mononuclear cells (PBMC) were isolated
from venous blood by density gradient centrifugation using Fi-
coll-Plaque® Plus (Amersham Pharmacia Biotec, Piscataway
NJ). CD41, CD41CD45RA (naive), and CD41CD45RO
(memory) cells were isolated using magnetic cell separation
(MACS) MicroBeads technology (Miltenyi Biotec GmbH, Ber-
gisch Gladbach, Germany) as before.(12) CD41 cells were neg-
atively selected using the human CD4 MultiSort Kit (Miltenyi
Biotec). For isolation of naive and memory cells, the isolated
CD41 cells were labeled with anti-CD45RA and anti-CD45RO
Microbeads, respectively. Purity of the subpopulations was
checked by staining with the appropriate cell surface markers
and was consistently between 96% and 99%. RNAs were iso-
lated by TRIzol LS reagent (Life Technologies, Grand Island,
NY), and a second cleanup step was performed using the Qia-
gen RAeasy total RNA isolation kit (Qiagen, Valencia, CA).
Ribonuclease protection assays (RPA)
Age-related changes in T cell chemokine receptor gene ex-
pression were examined by RPAs. The probes were synthesized
by modification of the manufacturer’s protocol. Briefly, GACU
nucleotide pool and a32P-UTP, RNasin, T7 RNA polymerase
were added to the multiprobe template set hCR-5 (CCR-1, -3,
-4, -5, -8, -2a/b, -2a, -2b) (BD PharMingen, San Diego, CA)
and placed on a heat block at 37°C for 1 h. The reaction was
terminated by adding DNAse and incubated at 37°C on a heat
block for 30 min. Appropriate volumes of EDTA, Tris-satu-
rated phenol, chloroform/isoamyl alcohol (CIAA, 50:1), and
yeast tRNA were then added to the mixture, as suggested by
the manufacturer. The aqueous layer was extracted by CIAA,
then pelleted by adding a 1:5, 4 M ammonium acetate and ice-
cold 100% ethanol mixture. Total RNA (5 mg) from each T cell
sample was used for hybridization. The protected probes were
allowed to be resolved by electrophoresis using a 5% acry-
lamide gel, exposed to a phosphor screen, and quantified by a
PhosphorImager using Image Quant software (Molecular Dy-
namics, Sunnyvale, CA).
Western blots
To determine if changes in chemokine receptor expression
caused similar changes in protein expression, Western blot
analyses were performed as before.(12) Briefly, proteins were
isolated from CD41 T cells from 14 young and 14 old subjects
and resolved on 10% SDS-PAGE, then transferred to nitrocel-
lulose-1 membranes (Life Technologies, Gaithersburg, MD).
The membranes were allowed to react with antihuman CCR4
and CCR5 antibodies (Research Diagnostics Inc., Flanders, NJ).
Detection was performed using the ECL system (Amersham
Life Science). The membranes were stripped and reprobed with
anti-b-actin antibodies (Sigma-Aldrich, St. Louis, MO) to con-
firm equal protein loading.
Statistical analysis
Data analysis was performed with Stata 7.0 (Stata Corpora-
tion, College Station, TX). The results are expressed as the
mean 6 standard error. Where indicated, comparisons between
young and old T cells were carried out using the nonparamet-
ric Mann-Whitney U-test, as chemokine receptor levels may
not be normally distributed in either age group. A p value #0.05
is considered significant.
RESULTS
Effect of aging on PBMC CC chemokine 
receptor expression
To determine if the observed aging-associated increased CC
chemokine receptor expression in murine T cells also occurs in
humans, CC chemokine receptor expression of PBMCs from
young (n 5 15; mean age 25 years, range 20–32) and old (n 5
14; mean age 73 years, range 60–80) subjects was examined
by RPAs. The results showed that aging is associated with sig-
nificant increased gene expression of CCR1–5 (Fig. 1).
Effect of aging on CD41 T cell CC chemokine
receptor expression
We then determined if the age-related changes occurred in
specific T cell compartments in humans. CC chemokine re-
ceptor expression of CD41 from young (n 5 16; mean age 27
years, range 20–39) and old (n 5 14; mean age 78 years, range
66–95) subjects was examined by RPA. The results were sim-
ilar to those for total PBMCs, with increased CCR1–5 in CD41
T cells in human aging (Fig. 2).
Effect of aging on naive and memory CD41 T cell CC
chemokine receptor expression
Aging is associated with the expansion of the T memory cell
compartment. Selective CC chemokine receptors are also pref-
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erentially expressed in memory vs. naive T cells. To exclude
the possibility that the observed aging-associated increase in
CC chemokine receptor represents changes in CD41 T cell sub-
sets, we determined the CCR1–5 expression in naive and mem-
ory CD41 T cells in young (n 5 8; mean age 27.9 6 6.0 years,
range 20–38) and old (n 5 8; mean age 77.6 6 8.8 years, range
67–95) subjects. The results show that the aging effects were
present in both the naive and memory subsets. However, the
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FIG. 1. CCR1–5 gene expression in PBMCs in aging as measured by RPA. CCR1–5 gene expression in PBMCs from 15 young
and 14 old subjects was measured. An autoradiograph of representative RPA showing CR gene expression of 7 young and 6 old
subjects is shown. The bar graphs represent the p value and mean 6 SEM of each of the CR measured. Gel loading is corrected
with L32 expression. p values comparing young and old are shown. The level of CCR8 gene expression is considered too low
to be reliable.
biggest increase in CCR expression occurred in the memory
CD41 cell compartment (Fig. 3), suggesting that the primary
defects reside in the memory T cell subset.
Effects of aging on CD41 T cell CC chemokine
receptor protein expression
In general, the chemokine receptor protein levels are quite
low in unstimulated T cells. However, consistent with the RPA
data, the Western blot results showed increased CCR4 and
CCR5 protein levels in CD41 T cells from old (n 5 14; mean
age 77.5 6 10.3 years, range 60–95) compared with 14 young
(n 5 14, mean age 25.4 6 5.8 years, range 20–39) subjects
(Fig. 4).
DISCUSSION
HIV-1 infection in the elderly is the fastest growing segment
of the AIDS epidemic in this country. Because of the graying
of America, coupled with the lack of awareness/misconception
of many healthcare professionals, older adults with HIV-1 in-
fection have been called the “overlooked epidemic” and the
“forgotten population.”(14) In addition to having a shorter ob-
served AIDS-free interval, older adults infected with the HIV
virus have more severe disease and shorter survival.(1–5) How-
ever, the reasons behind these observations are unclear. Postu-
lated mechanisms include cofactors, such as poor nutrition, co-
existing infections, and other aging-related comorbidities. It
also has been suggested that higher levels of P-glycoprotein (P-
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FIG. 2. The effects of aging on CD41 T cell CCR1–5 gene expression as measured by RPA. CD41 T cells were isolated from
16 young and 14 old subjects by magnetic beads. RNAs from the freshly isolated cells were subjected to RPA. The intensity of
the bands was quantified using a PhosphorImager. A representative autoradiograph is shown. Gel loading is corrected with L32
expression. The results represent the p values and the mean 6 SEM and are similar to the results obtained with the PBMCs.
gp), the ATP-dependent plasma membrane pump that mediates
multiple drug resistance, in aged T cells lead to resistance to
antiviral medications.(15) Poor antibody response and poor per-
formance by T lymphocytes of older adults(16) also have been
proposed as possible factors causing the worse HIV clinical out-
come in the elderly. However, although increased T cell P-gp
activity has been demonstrated convincingly in aging rodents,
others have found that the proportion of P-gp1 T and B cells
increases in human adulthood but declines after age 60.(17)
The HIV RNA plasma level has been shown to be the most
important predictor of HIV-1 disease progression and out-
come.(18) However, there is wide interpatient variability in vi-
ral load among HIV-infected patients, and the host factors re-
sponsible for this variability are incompletely understood. Sev-
eral chemokine receptors (CCR2b, CCR3, CCR5, CXCR4) or
orphan, chemokine-like molecules (GPR1, GPR15, V28, APJ)
have been shown to be coreceptors for HIV-1 entry and repli-
cation, but the initially described CXCR4 and CCR5 molecules
remain the principal coreceptors for X4 (T cell-tropic or syn-
cytium inducing) or R5 (macrophage [M]-tropic or nonsyn-
cytium inducing) isolates, respectively.(7–9) CCR5 density on
CD41 T cells has been shown recently to correlate closely to
the level of viral load(10) and disease progression.(11) Thus, pa-
tients exhibiting high CCR5 expression have high viral load,
AGING AND DECLINE IN DEFENSIVE ABILITY 579
FIG. 3. RPAs showing the effects of aging on CCR1–5 gene expression of naive and memory CD41 T cells. Naive and mem-
ory cells were isolated from 8 young (mean age 28 years) and 8 old (mean age 78 years) subjects. The results represent the
mean 6 SD of the 8 subjects in each of the four groups. The p values are also shown.
and those with low CCR5 expression have low viral load. The
importance of CCR5 in HIV-1 is also illustrated by the effect
of a 32-bp deletion in the CCR5 gene. Subjects who are ho-
mozygous for this D32 deletion have very low levels of CCR5
expression and are resistant to HIV-1 infection. In addition,
those with the heterozygous mutation have much slower pro-
gression of the disease.(19) Importantly, the correlation between
CCR5 expression and viremia is logarithmic. Even a small dif-
ference in CCR5 expression causes a marked difference in HIV
RNA plasma load.
There is currently very little available information on the ef-
fect of aging on T cell chemokine receptor function. Tarazona
et al.(20) showed decreased CCR7 expression on natural killer
(NK) cells in elderly individuals and suggested that this is due
to the accumulation of memory T cells. Carramolino et al.(21)
recently examined CCR9 expression during development and
showed that in mouse thymocytes, CCR9 is expressed at all
stages of T cell maturation, with maximum expression in
CD41CD81 cells. Expression of thymic CCR9 maintains or de-
creases slightly during the first year of life. The investigators
also found that secondary lymphoid organ’s CD4 cells lose but
CD8 cells maintain CCR9 expression in the neonatal period.
The study suggests that age and development affect chemokine
receptor expression. However, as the oldest animals examined
were only 12 months old, the effect of aging on CCR9 expres-
sion is unknown.
We recently examined the effect of aging on murine T cell
chemokine expression by microarray screening and RPA.(12)
We showed that CD41 T cells from aged mice had increased
CCR1, 2, 4, 5, and 8 and CXCR2–5 and a lower level of CCR7
and 9. CCR3 expression may also be decreased in aging, al-
though the results did not reach statistical significance. In this
report, we extended our observations and show for the first time
that aging is associated with the increase in human lymphocyte
CCR1–5 chemokine receptor expression. Our initial experi-
ments determined CCR1–5 gene expression in unfractionated
PBMCs and CD41 T cells from young and old subjects. The
results were similar to the murine data and showed increased
T cell CCR1–5 expression in human aging. Both murine and
human aging are associated with the accumulation of memory
T cells.(13) Naive and memory T cells also have a different
repertoire of chemokine receptors. For example, CCR4,(22)
CCR5, and CXCR3(22,23) expressions are increased in memory
T cells, whereas CCR7(24) and CXCR4(23) are primarily ex-
pressed on naive T cells. Importantly, naive and memory CD41
T cells also differ in their susceptibility to HIV-1 infection, at
least in part due to their differential chemokine response to T
cell receptor stimulation.(25,26) Because we did not examine the
effect of aging on naive and memory cell chemokine receptor
expression in the murine study, it is possible that the observed
changes are purely the result of increased memory compartment
in aging. In the current study, we isolated naive and memory
CD41 T cells from the peripheral blood of young and old sub-
jects and showed that the aging-associated increase in CCR oc-
curs in both naive and memory T cells. This suggests that the
observed chemokine receptor changes are not simply the results
of bias in favor of T memory subset in the elderly. Furthermore,
expression of CCR1, 2, and 3 is not known to be associated
with memory T cells. However, we also found that the most
pronounced aging-associated increase in CCR gene expression
occurred in the memory CD4 subset. Thus, the expansion of
the memory T cell compartment in aging likely contributes to,
but does not fully explain, the observed increased expression
of memory CCR markers, including CCR4 and CCR5 in CD41
T cells.
The mechanisms for the observed increased CCR1–5 
expression in aging are unclear. The regulation of gene ex-
pression is dependent on the presence of DNA-binding 
transcription factors and processes determining the ability of
transcriptional factors to bind to the target DNA in promoter
elements. A number of transcription factors have been shown
to be involved in regulating chemokine receptor gene expres-
sion. For example, NF-kB consensus binding sequences have
been found in the promoter regions of chemokine receptor
genes, including CCR5.(27,28) However, others have shown that
aging has a tissue-specific effect on transcription factor activ-
ity, with a general decline in NF-kB expression in T cells.(29,30)
Furthermore, different CC chemokine receptor genes are likely
regulated by different transcription factors. The decreased tran-
scription factor activity in T cells in aging is, therefore, not
likely to be the mechanism responsible for the observed in-
creased chemokine receptor expression. Interestingly, the hu-
man CCR1–3 and 5 are all located on the chromosome locus
3p21.31, and the CCR4 gene is on 3p24.(7) The close proxim-
ity and the concurrent upregulation of these chemokine recep-
tors suggest the possibility that epigenetic mechanisms that af-
fect chromatin structure may be involved in the regulation of
chemokine receptor gene expression in aging.
Our current findings may have important implications in our
understanding of T cell chemokine receptor-dependent diseases,
including HIV-1 infection, in the elderly. The early stages of
HIV-1 infection in vivo are dependent on HIV variants that use
CCR5 as the coreceptor for entry into T cells and monocytes.
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FIG. 4. Western blot analysis of CCR4 and CCR5 protein
levels in CD41 T cells from 14 young and 14 old subjects. The
results are expressed relative to the first young subject (1) and
are corrected for protein loading using the b-actin bands. The
results show the mean 6 SEM of CD41 T cells from young
and old subjects. The p values are shown.
The level of T cell CCR5 expression also correlates closely to
HIV viral load and disease progression. Importantly, memory
CD41 T cells are the predominant targets for multiple HIV-1
isolates (both R5 and X4).(31) Thus, our findings that CCR5
overexpression occurs in aging memory CD41 T cells may pro-
vide a mechanism explaining the worse clinical outcome in
HIV-1 infection in the elderly.
In summary, we showed that human aging is associated with
the increased expression of CCR1–5 in PBMCs and CD41 T
cells. These changes are not restricted to either memory or naive
T cell subset and are not explained by the expansion of the
memory T cell compartment in aging. The results support the
hypothesis that the increased susceptibility and accelerated clin-
ical progression of HIV-1 infection in older adults may be in
part due to age-related changes in leukocyte CC chemokine re-
ceptor expression.
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